Baxter Recalls Milrinone Lactate Injection Due to Sterility Concerns
Baxter Healthcare is recalling Milrinone Lactate in Dextrose Injection because customer complaints reported leaks, creating a lack of assurance of sterility.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II. Per the rubric, FDA Class II recalls with potential for significant injury (such as sterility failure in an IV drug) are rated as Severe (4), as they are not Class I but involve serious health risks.
Plain-English summary
Baxter Healthcare Corporation is recalling 90,450 bags of Milrinone Lactate in 5% Dextrose Injection, 20 mg/100 mL, 100 mL Single-Dose Intravia Container bags. The recall was initiated due to customer complaints regarding the presence of leaks in the product, which resulted in a lack of assurance of sterility.
The affected product is a prescription-only intravenous medication manufactured by Baxter Healthcare Corporation in Deerfield, IL. The specific lots involved are P342485 (Expiration 11/30/17) and P344408 (Expiration 12/31/17). The product was distributed in the United States and foreign countries, including the United Arab Emirates, Colombia, and Canada.
Healthcare providers and patients should stop using the affected lots and contact Baxter Healthcare Corporation for further instructions or to arrange for a return or replacement. This recall is classified as Class II by the FDA, indicating a reasonable probability that the use of the product could cause temporary or medically reversible adverse health consequences.
The recalled product
- Product
- MILRINONE LACTATE IN DEXTROSE (MILRINONE LACTATE)
- Brand
- MILRINONE LACTATE IN DEXTROSE
- Manufacturer
- Baxter Healthcare Corporation
- Category
- Drug — Intravenous Injection
- Affected units
- 90,450
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot #: P342485
- Exp 11/30/17
- P344408
- Exp 12/31/17
Distribution
Distribution scope not specified by the agency.
Part of a larger recall action
This product is one of 2 recalled by Baxter Healthcare Corporation under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same manufacturer · Baxter Healthcare Corporation
See all →- SevereBaxter Recalls Cefazolin Injection Bags Due to Particulate Matter
FDA (Drugs) · 2026-08-19
- HighBaxter Duo-Vent Solution Set Recalled for Air Bubbles in Tubing
FDA (Devices) · 2026-08-19
- SevereHillrom VOLARA System P.CIRCUIT KIT Medical Device Recall for Oxygen Drop Risk
FDA (Devices) · 2026-07-08
- SevereHillrom VOLARA P.CIRCUIT Medical Device Nebulizer Cup Leakage Recall
FDA (Devices) · 2026-07-08
- SevereHillrom VOLARA System patient circuits recalled for nebulizer leakage risk
FDA (Devices) · 2026-07-08
Same hazard · sterility failure
See all →- SevereROHTO DIGI-EYE Eye Drops Recalled Over Sterility Assurance Gap
FDA (Drugs) · 2026-07-29
- HighROHTO DRY-AID Eye Drops Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- SevereTransvenous Pacing Electrode Tray with Bipolar Balloon Pacing Electrode Recalled
FDA (Devices) · 2026-07-22
- SevereArterial Line Kit with Lidocaine HCL Injection Fails Sterility Testing
FDA (Devices) · 2026-07-22
- SevereOne-Piece Introducer Tray kits recalled for sterility failure
FDA (Devices) · 2026-07-22